Article Details

Equillium Announces Initiation of the Phase 3 EQUATOR Study of Itolizumab in First-line ...

Retrieved on: 2022-03-05 23:25:53

Tags for this article:

Click the tags to see associated articles and topics

Equillium Announces Initiation of the Phase 3 EQUATOR Study of Itolizumab in First-line .... View article details on hiswai:

Excerpt

Details: Category: Antibodies: Published on Saturday, 05 March 2022 18:21 ... Itolizumab, a first-in-class monoclonal antibody that targets the ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up